3 For reviews on nitrogen-centered radicals, see: (a) R. S. Neale,
Synthesis, 1971, 1; (b) P. Mackiewicz and R. Furstoss, Tetrahedron,
1978, 34, 3241; (c) L. Stella, Angew. Chem., Int. Ed. Engl., 1983, 22,
337; (d) J. L. Esker and M. Newcomb, Adv. Heterocycl. Chem.,
1993, 58, 1; (e) S. Z. Zard, Synlett, 1996, 1148; (f) A. G. Fallis and
I. M. Brinza, Tetrahedron, 1997, 53, 17543; (g) S. Z. Zard, Chem.
Soc. Rev., 2008, 37, 1603; (h) D. P. Curran, in Comprehensive
Organic Synthesis, ed. B. M. Trost and I. Fleming, Pergamon
Press, Oxford, 1991, vol. 4, ch. 4.2, pp. 811–812; (i) L. Stella, in
Radicals in Organic Synthesis, ed. P. Renaud and M. P. Sibi,
Wiley-VCH, Weinheim, 2001, vol. 2, ch. 51, pp. 407–426;
(j) M. Minozzi, D. Nanni and P. Spagnolo, Chem.–Eur. J., 2009,
15, 7830.
Scheme 6 Synthesis of protected 1,4-dideoxy-1,4-imino-L-ribitol.
4 There is only one example of a 6-endo cyclization of a nitrogen-
centered radical onto an alkyl enol ether, which was part of a study
on lone-pair repulsion during radical cyclizations: X. Yuan, K. Liu
and C. Li, J. Org. Chem., 2008, 73, 6166.
5 For 5-exo cyclizations of oxygen-centered radicals onto silyl enol
ethers, see: M. Zlotorzynska, H. Zhai and G. M. Sammis, Org.
Lett., 2008, 10, 5083.
6 For
a representative example of nitrogen-centered radical
formation from the homolysis of sulfenamides, see:
W. R. Bowman, D. N. Clark and R. J. Marmon, Tetrahedron,
1994, 50, 1275.
Fig. 3 Proposed mechanism for the formation of imine 27.
7 For initial studies, see: (a) S. Kim, G. H. Joe and J. Y. Do, J. Am.
Chem. Soc., 1993, 115, 3328; (b) S. Kim, G. H. Joe and J. Y. Do,
J. Am. Chem. Soc., 1994, 116, 5521; For calculations indicating
that tin-bound aminyl radicals are more nucleophilic than free
aminyl radicals, see: ; (c) S. Kim, K. M. Yeon and K. S. Yoon,
Tetrahedron Lett., 1997, 38, 3919.
8 R. J. Nash, E. A. Bell, G. W. J. Fleet, R. H. Jones and
J. M. Williams, J. Chem. Soc., Chem. Commun., 1985, 738.
9 CYB-3 has been found to exhibit modest glycosidase inhibition:
A. M. Scofield, L. E. Fellows, R. J. Nash and G. W. J. Fleet, Life
Sci., 1986, 39, 645.
10 For early syntheses of 2-hydroxymethyl-3-hydroxypyrrolidine and
protected derivatives,see: (a) N. Ikota and A. Hanaki, Hetero-
cycles, 1988, 27, 2535; (b) R. C. Roemmele and H. Rapoport,
J. Org. Chem., 1989, 54, 1866; (c) P. Merino, I. Delso, T. Tejero,
F. Cardona, M. Marradi, E. Faggi, C. Parmeggiani and A. Goti,
Eur. J. Org. Chem., 2008, 2929; (d) M. Toumi, F. Couty and
G. Evano, Tetrahedron Lett., 2008, 49, 1175; (e) J. M. Schomaker,
S. Bhattacharjee, J. Yan and B. Borhan, J. Am. Chem. Soc., 2007,
129, 1996; (f) M. Toumi, F. Couty and G. Evano, Angew. Chem.,
Int. Ed., 2007, 46, 572; (g) D. J. Michaelis, M. A. Ischay and
T. P. Yoon, J. Am. Chem. Soc., 2008, 130, 6610.
that if the concentration of tributyltin hydride is minimized
during the cyclization, one may be able to favor the imine
product. Indeed slow addition of tributyltin hydride leads
to greater conversion to cyclic imine 27. Correspondingly,
increasing the concentration of tributyltin hydride through
fast addition resulted in only minimal amounts of imine
formation, which is consistent with the proposed mechanism.
In summary, we have developed a general method for the
synthesis of substituted 2-hydroxymethyl pyrrolidines, a key
structural motif in the polyhydroxylated alkaloids. Our route
utilizes a nitrogen-centered radical cyclization onto a silyl enol
ether. We have demonstrated the synthetic potential of this
methodology in the synthesis of 2-hydroxymethyl-3-hydroxy-
pyrrolidine and in the synthesis of 1,4-dideoxy-1,4-diamino-L-
ribitol. Efforts to further investigate the stereochemical aspects
of the cyclization and to explore this new nitrogen-centered
radical cyclization in the context of complex polyhydroxylated
alkaloids and related analogs are currently underway.
This work was supported by the University of British
Columbia, the Natural Sciences and Engineering Research
Council of Canada (NSERC), and a doctoral fellowship from
NSERC to M.Z.
11 For
a synthesis of (S)-methyl-3,5-dihydroxypentanoate, see:
B. Loubinaux, J.-L. Sinnes, A. C. O’Sullivan and T. Winkler,
Tetrahedron, 1995, 51(12), 3549.
12 For stereoselectivity models in radical cyclizations, see: (a) A. L.
J. Beckwith and C. H. Schiesser, Tetrahedron, 1985, 41, 3925;
(b) D. C. Spellmeyer and K. N. Houk, J. Org. Chem., 1987,
52, 959.
13 Synthesis of E-enriched silyl enol ethers was accomplished using
TBSCl and DBU at 35 1C providing selectivities greater than 90 :
10 E–Z. Synthesis of Z-enriched silyl enol ethers was accomplished
using TBSOTf and diisopropylethylamine at 0 1C providing
selectivities greater than 60 : 40 Z–E. The selectivities for TES
enol ether formation were lower. See ESIw for details.
14 For early syntheses of 4-dideoxy-1,4-imino-L-ribitol and protected
derivatives, see: (a) H. Setoi, H. Kayakiri, H. Takeno and
M. Hashimoto, Chem. Pharm. Bull., 1987, 35, 3995; (b) G. W.
J. Fleet, J. C. Son, D. C. Green, I. C. Bello and B. Winchester,
Tetrahedron, 1988, 44, 2649. For recent, enantioselective syntheses
of 1,4-dideoxy-1,4-imino-L-ribitol, see: (c) S.-Y. Luo,
S. S. Kulkarni, C.-H. Chou, W.-M. Liao and S.-C. Hung,
J. Org. Chem., 2006, 71, 1226; (d) M. Marradi, S. Cicchi,
J. I. Delso, L. Rosi, T. Tejero, P. Merino and A. Goti, Tetrahedron
Lett., 2005, 46, 1287.
Notes and references
1 For recent reviews, see: (a) B. Winchester and G. W. J. Fleet,
Glycobiology, 1992, 2, 199; (b) A. E. Stutz, Iminosugars as
¨
Glycosidase Inhibitors: Nojirimycin and Beyond, Wiley-VCH,
Weinheim, 1999; (c) A. A. Watson, G. W. J. Fleet, N. Asano,
R. J. Molyneux and R. J. Nash, Phytochemistry, 2001, 56, 265;
(d) T. M. Wrodnigg, Monatsh. Chem., 2002, 133, 393;
(e) P. Compain and O. R. Martin, Curr. Top. Med. Chem., 2003,
3, 541.
2 (a) G. Legler, Adv. Carbohydr. Chem. Biochem., 1990, 48, 319;
(b) N. Asano, H. Kizu, K. Oseki, E. Tomioka, K. Matsui,
M. Okamoto and M. Baba, J. Med. Chem., 1995, 38, 2349;
(c) N. Asano, R. J. Nash, R. J. Molyneux and G. W. J. Fleet,
Tetrahedron: Asymmetry, 2000, 11, 1645; (d) T. D. Butters,
R. A. Dwek and F. M. Platt, Curr. Top. Med. Chem., 2003, 3, 561.
ꢀc
This journal is The Royal Society of Chemistry 2009
5718 | Chem. Commun., 2009, 5716–5718